Cargando…
The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells
Increased osteoclast-mediated bone resorption is characteristic of osteoporosis, malignant bone disease and inflammatory arthritis. Targeted deletion of Sirtuin1 (Sirt1), a key player in aging and metabolism, in osteoclasts results in increased osteoclast-mediated bone resorption in vivo, making it...
Autores principales: | Gurt, Irina, Artsi, Hanna, Cohen-Kfir, Einav, Hamdani, Gilad, Ben-Shalom, Gal, Feinstein, Ben, El-Haj, Madi, Dresner-Pollak, Rivka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520518/ https://www.ncbi.nlm.nih.gov/pubmed/26226624 http://dx.doi.org/10.1371/journal.pone.0134391 |
Ejemplares similares
-
SRT2183 and SRT1720, but not Resveratrol, Inhibit Osteoclast Formation and Resorption in the Presence or Absence of Sirt1
por: Thiyagarajan, Ramkumar, et al.
Publicado: (2023) -
Sirt1 Promotes a Thermogenic Gene Program in Bone Marrow Adipocytes: From Mice to (Wo)Men
por: Artsi, Hanna, et al.
Publicado: (2019) -
The Sirt1 activator SRT3025 provides atheroprotection in Apoe(−/−) mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
por: Miranda, Melroy X., et al.
Publicado: (2015) -
SRT2183 impairs ovarian cancer by facilitating autophagy
por: Sun, Tingting, et al.
Publicado: (2020) -
SIRT1 haplo-insufficiency results in reduced cortical bone thickness, increased porosity and decreased estrogen receptor alpha in bone in adult 129/Sv female mice
por: Artsi, Hanna, et al.
Publicado: (2022)